[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Herpes Zoster (Shingles) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: H717247051CAEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Herpes Zoster (Shingles) Drug pipeline report- 2020 is an annual R&D review of Herpes Zoster (Shingles) pipeline candidates. The report presents the current status of all major Herpes Zoster (Shingles) therapeutic compounds. Detailed insights into Herpes Zoster (Shingles) pipeline development, current status, companies, drug profiles and Herpes Zoster (Shingles) preclinical and clinical trials are included.

2020 Herpes Zoster (Shingles) Pipeline Market Insights
Herpes Zoster (Shingles) disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Herpes Zoster (Shingles) therapies, pipeline by phase and others are included.

Herpes Zoster (Shingles) pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Herpes Zoster (Shingles) Therapeutic Drug candidates
Both active and inactive Herpes Zoster (Shingles) pipeline drug candidates are included in the report

Herpes Zoster (Shingles) Clinical Trials and preclinical Studies
Herpes Zoster (Shingles) In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Herpes Zoster (Shingles) pipeline market developments
Herpes Zoster (Shingles) Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Herpes Zoster (Shingles) pipeline companies in active development
The report analyzes Herpes Zoster (Shingles) pipeline of the below companies-

ContraVir Pharmaceuticals Inc , CPL Biologicals Pvt Ltd, Curevo Inc, GeneOne Life Science Inc, N & N Pharmaceuticals Inc, NAL Pharmaceuticals Ltd, NanoViricides Inc, Tianjin CanSino Biotechnology Inc, Vaccitech Ltd, XBiotech Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
10 Companies investing in Herpes Zoster (Shingles) pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Herpes Zoster (Shingles) pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. HERPES ZOSTER (SHINGLES) PIPELINE MARKET INSIGHTS, 2020

1.1 Herpes Zoster (Shingles) Disease Overview
1.2 Herpes Zoster (Shingles) Drug Pipeline Snapshot, 2020
  1.2.1 Herpes Zoster (Shingles) Pipeline Drugs by Phase
  1.2.2 Herpes Zoster (Shingles) Pipeline Drugs by Company
  1.2.3 Herpes Zoster (Shingles) Pipeline Drugs by Mechanism of Action
  1.2.4 Herpes Zoster (Shingles) Pipeline Drugs by Route of Administration

2. HERPES ZOSTER (SHINGLES) COMPANY WISE PIPELINE DETAILS

ContraVir Pharmaceuticals Inc Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
CPL Biologicals Pvt Ltd Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Curevo Inc Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
GeneOne Life Science Inc Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
N & N Pharmaceuticals Inc Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
NAL Pharmaceuticals Ltd Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
NanoViricides Inc Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tianjin CanSino Biotechnology Inc Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaccitech Ltd Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details
XBiotech Inc Herpes Zoster (Shingles) Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. HERPES ZOSTER (SHINGLES) DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. HERPES ZOSTER (SHINGLES) PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications